{
    "id": "0226",
    "question": "A 51-year-old man presents for a routine check-up. He has no complaints. At his last annual visit, his physical and laboratory tests were unremarkable. His past medical history is significant for hypercholesterolemia, well managed with rosuvastatin, and hypertension, well managed with hydrochlorothiazide. His current medications also include aspirin. The patient is afebrile, and his vital signs are within normal limits. Physical examination is unremarkable. His laboratory tests are significant for the following:\nWBC 29,500/mm3\nHematocrit 26.1%\nHemoglobin 9.1 g/dL\nPlatelet count 298,000/mm3\nA peripheral blood smear and differential shows 92% small normocytic lymphocytes. The patient\u2019s diagnosis in confirmed by bone marrow biopsy and flow cytometry. He is monitored through regular follow-up visits. Three years after the initial diagnosis, the patient presents with swollen cervical and axillary lymph nodes, unintentional weight loss of 4.5 kg (approx. 10 lb), and \u201crib pain\u201d on his right side. On physical examination, there is palpable, firm, non-tender cervical and axillary lymphadenopathy bilaterally. He also has moderate splenomegaly, which, when palpated, elicits pain. Which of the following is the best treatment for this patient\u2019s most likely diagnosis?",
    "options": {
        "A": "Bleomycinrn",
        "B": "Imatinib",
        "C": "Fludarabinern",
        "D": "Vincristinern"
    },
    "answer": "C",
    "predict": "To approach this question, let's break down the patient's presentation and history: 1. **Initial Presentation**: The patient is a 51-year-old man with no complaints, but he has a history of well-managed hypercholesterolemia and hypertension. His laboratory tests show an elevated white blood cell count (WBC 29,500/mm^3), low hematocrit (26.1%), low hemoglobin (9.1 g/dL), and a high platelet count (298,000/mm^3). The peripheral blood smear and differential show 92% small normocytic lymphocytes. 2. **Diagnosis**: The patient's diagnosis is confirmed by bone marrow biopsy and flow cytometry. The presence of 92% small normocytic lymphocytes in the peripheral blood smear and lymphadenopathy suggest a lymphoproliferative disorder. 3. **New Symptoms and Physical Examination Findings**: Three years after the initial diagnosis, the patient presents with swollen cervical and axillary lymph nodes, unintentional weight loss, and \"rib pain\" on one side. The physical examination reveals palpable, firm, non-tender cervical and axillary lymphadenopathy bilaterally, and moderate splenomegaly with pain on palpation. Considering the patient's history, symptoms, and physical examination findings, the most likely diagnosis is **Chronic Lymphocytic Leukemia (CLL)**, also known as Chronic Lymphocytic Lymphoma (CLL/Lymphoma). Now, let's evaluate the treatment options: - **A. Bleomycin**: This is an antineoplastic antibiotic used in the treatment of certain types of cancer, including Hodgkin lymphoma and testicular cancer. It is not a standard treatment for CLL. - **B. Imatinib**: This is a tyrosine kinase inhibitor used in the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It is not a standard treatment for CLL. - **C. Fludarabine**: This is a purine analog used in the treatment of CLL. It is a common chemotherapeutic agent for CLL and is often used in combination with other medications. - **D. Vincristine**: This is an alkylating agent used in the treatment of various types of cancer, including lymphomas and leukemias. However, it is not the first-line treatment for CLL. **Answer**: The best treatment for CLL is a combination of chemotherapy, targeted therapy, or immunotherapy, depending on the specific subtype and stage of the disease. Given the options provided, **Fludarabine** is the most appropriate choice for this patient's likely diagnosis of CLL.",
    "snippets": [],
    "scores": [],
    "execution_time": 23.835500240325928
}